Click on the paperclip at the top of the page to add, remove or edit files. If possible, please add a row to the table below to allow easy access to your slides.
Meeting date | Uploaded by | Slides | Comments |
|---|---|---|---|
2 May 2012 | Julie | PFIM Interface 3.1 - cours M2R 10-11.pdf |
|
15 May 2012 | Angelina |
| |
6 June 2012 | Joe |
| |
13 June 2012 | Joanna | EMA geriatric workshop - March 2012 - Shepard (submitted 19March).ppt | Terry Shepard's Slides |
12 October 2012 | Rollo |
| |
9 November 2012 | Joanna |
| |
13 November 2012 | Julie |
| |
14 December 2012 | Lilia | Modelling neutrophil dynamics in children following bone marrow transplant |
|
22 Februrary 2013 | Allienor Berges |
| |
1 March 2013 | Rollo |
| |
28 May 2013 | Charlotte |
|
List of past meetings:
9 May 2012 | PUW1 | Joanna | Immunology |
16 May 2012 | WCJ | Angelina | Zidovudine PK/PG |
23 May 2012 | PUW2 | Jig | LMWH in pregnancy |
30 May 2012 | No meeting |
|
|
6 June 2012 | PUW1 | Joe | Antimicrobial PKPD |
13 June 2012 | PUW1 | Terry Shepard | Geriatric PKPD |
20 June 2012 | PUW2 | Rollo/Joanna | Immunology modelling |
27 June 2012 | No meeting |
|
|
4th July 2012 | No meeting |
|
|
11th July 2012 | PUW2 | Julie | PAGE review |
18th July 2012 | PUW2 | Katie | Gentamicin in burns |
12/10/12 1pm | WCA | Rollo | Modelling of the immune reconstitution post BMT |
19/10/12 1pm | PUW3 | Joe | Prague Biometrics 2012;68:902-11 |
26/10/12 1pm | PUW3 | Charlotte | NAPPA (Beta lactam pharmacokinetics/pharmacodynamics) plans |
2/11/12 1pm | PUW3 | Eva | Neogent (developing Bayesian therapeutic drug monitoring) progress |
9/11/12 1pm | PUW3 | Joanna | Inference methods course review |
16/11/12 1pm | PUW2 |
| General discussion |
23/11/12 1pm | PUW3 | Julie | Covariate selection methods in pharmacokinetic modelling |
30/11/12 1pm | PUW3 | Julie | NCA versus modelling in phase I studies for drugs with long half-life |
7/12/12 1pm | PUW3 |
| Goldacre talk |
14/12/12 1pm | PUW3 | Lilia | Neutropenia post-BMT |
4/1/13 1pm | PUW3 |
| General discussion |
11/1/13 1pm | Levinsky | Joe | Maraviroc PK |
18/1/13 1pm | PUW4 | Andrezj | PKPD bridging of response between adults and children |
25/1/13 1pm | PUW3 | Lilia | Neutropenia following paediatric BMT |
1/2/13 1pm | PUW1 | Mirjam Trame | Use of PKPD modeling to guide HIV understanding and treatment |
8/2/13 1pm | PUW3 | Sami | Bioequivalence studies and genetic variability |
15/2/13 1pm | PUW1 | Liana | ErbB inhibition for PKD |
22/2/13 1pm | PUW3 | Alienor Berges (GSK) |
|
1/3/13 1pm | PUW4 | Rollo | CD4 reconstitution post BMT |
8/3/13 1pm | PUW3 | Eva | Neogent update |
15/3/13 1pm | PUW4 | Tafi | Dose individualisation in HIV/AIDS and TB patients on Efavirenz (EFV). |
22/3/13 1pm | PUW3 | Hui Ma | Genetic components to glucose-insulin response |
26/4/13 1pm | PUW3 | Sarit | FA and bioavailability |
10/5/13 1pm | PUW3 | Tafi | Common adverse drug reactions linked to HIV and/or TB medication: Lipodystrophy, Skin Hypersensitivity, CNS and Peripheral Neuropathy. |
28/5/13 1pm | PUW1 | Charlotte | Use of meta-analysis in evidence synthesis: an example based on dose selection for antibiotics (PAGE talk) |
31/5/13 1pm | PUW1 | Rollo | Modelling immune reconstitution in children post HSCT (PAGE talk) |
7/6/13 1pm | PUW3 | Julie | Penalized regression implementation within the SAEM algorithm to advance high-throughput personalized drug therapy (PAGE talk) |
21/6/13 1pm | PUW1 | Bruce Green | Therapeutic Drug Monitoring |
16/9/13 1pm | PUW3 | Joe | Diagnostics for bivariate regression models |
23/9/13 1pm | PUW3 | No meeting | Julie Seminar on Tues 24/9. |
30/9/13 1pm | PUW2 | Jan-Stefan Van der Walt | Nonlinear mixed effects model for saliva cortisol and cortisone in patients with Addisons disease and healthy volunteers. |
1/10/13 1pm EXTRA MEETING | PUW4 | Stefanie Hennig | Changes in between subject variability with covariate models in pharmacometrics |
7/10/13 1pm | PUW2 |
|
|
14/10/13 1pm | PUW3 | Tafi | TBA |
21/10/13 1pm | PUW2 | Julie | Modelling of tenofovir and emtricitabine PK in the ANRS 134-COPHAR 3 trial (work in progress) |
28/10/13 1pm | PUW3 | Joanna | CD4 recovery in the CHER study |
4/11/13 1pm | PUW2 | Eva | Upgrade talk practice |
11/11/13 1pm | PUW3 | Flora Musuamba | Use of modelling and simulation tools to improve decision-making in drug development and clinical practice |
18/11/13 1pm | PUW2 | Joe | Decision theory and antimicrobials |
25/11/13 1pm | PUW3 | Andreas | Pain PKPD |
2/12/13 1pm | TWC F | No meeting |
|
9/12/13 1pm | PUW3 | Pieter de Cock | Paediatric antimicrobial PKPD in ICU |
16/12/13 1pm | PUW3 | Rollo | Modelling TCR repertoire (not with NLME!) |
20/1/14 | PUW3 | Jessica Soto | Modelling taste studies |
27/1/14 | PUW1 | Joanna | Practice for South Africa |
3/2/14 | PUW3 | Liana | PK of tyrosine kinase inhibitors in PKD animal model |
10/2/14 | PUW4 | Eva | Neogent predictions |
17/2/14 | PUW3 | Deji | Hepatitis and HIV co-infection modelling |
24/2/14 | PUW1 |
|
|
3/3/14 | PUW2 | Rollo | Upgrade practice |
10/3/14 | PUW1 | Joe | Clonidine PKPD for sedation in PICU |
17/3/14 | PUW3 | Andreas | Clinical protocol development for GAbapentine in Paediatric pain Project : Optimization of the trial design characteristics based on (E)D optimality using popED. |
24/3/14 | PUW3 | Julie | MRC Biostats talk on new methods for genetic covariates in PKPD modelling. |
31/3/14 | PUW1 | Flora | Clinical protocol development for GAbapentine in Paediatric Pain Project : Dose rationale and dosing schedule for characterisation efficacy in chronic pain |
7/4/14 | PUW3 | Morris | Development and dose rationale for fixed dose combinations for the treatment of tuberculosis |
14/4/14 | WCD | Andrezj | Population Pharmacokinetic Analysis of Efavirenz in African Children using mixture modelling to describe clearance multimodality |
26/4/14 | PUW4 |
|
|
12/5/14 | PUW2 | Carlos Hoyo | Nifedipine PKPD |
19/5/14 | WCC | Gavin Jarvis | A Modelling Approach to the Genetics of Embryonic Growth |
23/6/14 | PUW3 | All | PAGE meeting review |
30/6/14 | PUW2 | Flora | NLME cluster demonstration |
7/7/14 | PUW1 | Sophie Rhodes | The immune response to BCG vaccination over time and the population variation of immune response dynamics |
14/7/14 | PUW2 | Joanna and Jamie | An ODE model of peptide presentation by MHC-I / Geometric MCMC |
|
|
| SUMMER |
1/9/14 | LGSR | Joe | Antimicrobial PKPD IDM_clinpharm_Standing_2014.pdf |
8/9/14 meeting starts 2pm | Levinski | Julie | DDMore language |
15/9/14 | LGSR | Paul | Pharmacogenetics of diclofenac |
22/9/14 | LGSR | Yucheng | Count data models and introduction to Pirana |
29/9/14 | LGSR | Andreas | Gabapentin PKPD in paediatric neuropathic pain |
6/10/14 | LGSR | Liana | Tyrosine kinase inhibitor effects in polycystic kindney disease |
13/10/14 | LGSR | Joanna |
|
20/10/14 | LGSR | Rollo | Short-term neutrophil and lymphocyte HSCT models |
27/10/14 | LGSR | Eva | NeoGent PKUK practice |
3/11/14 | LGSR | Seb | Item Response Theory: Application to NLME |
10/11/14 | LGSR | Joe | A new mechanistic model for antiretroviral pharmacodynamics |
17/11/14 | LGSR | Alberto | Anaesthesia depth with 3 different EEG measures |
24/11/14 | LGSR | Suzanne Reeves | Mechanisms underpinning antipsychotic sensitivity in Alzheimer's disease |
1/12/14 | LGSR | Deji | Mixed Effect Modelling in Hep C-HIV coinfected children |
8/12/14 meeting starts at 2pm | LGSR | TBC | To be confirmed |
15/12/14 | LGSR | Morris | Understanding the determinants of drug exposure and pharmacokinetic variability in tuberculosis patients |